$40.24 $0.47 (1.2%)

01:14 PM EDT on 06/17/19

Anika Therapeutics, Inc. (NASDAQ:ANIK)

CAPS Rating: 2 out of 5

The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

Current Price $40.24 Mkt Cap $559.9M
Open $40.16 P/E Ratio 0.00
Prev. Close $39.77 Div. (Yield) $0.00 (0.0%)
Daily Range $39.87 - $40.68 Volume 21,556
52-Wk Range $29.08 - $41.81 Avg. Daily Vol. 4

Caps

How do you think NASDAQ:ANIK will perform against the market?

Add Stock to CAPS Watchlist

All Players

250 Outperform
8 Underperform
 

All-Star Players

27 Outperform
4 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top NASDAQ:ANIK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

staylo2561 (< 20)
Submitted March 11, 2014

The new approved drug is based on HRA, and is a one injection shot to the knee for osteoarthritis. I have taken HRA for years....It is a miracle drug.

tunstavurn (< 20)
Submitted March 02, 2011

Pending lawsuit with genzyme.declining marginsIncreased competition

NASDAQ:ANIK VS S&P 500 (SPY)

Fools bullish on NASDAQ:ANIK are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ANIK.

Recs

0
Member Avatar wstanislaw (34.56) Submitted: 7/7/2015 6:15:01 PM : Outperform Start Price: $32.57 NASDAQ:ANIK Score: -15.64

Great financials, zero debt, under valued based on growth history and potential. High demand got content arthritis treatment and a growing market if baby boomers will expand that demand. More potential in European and global markets, and existing foreign subsidiaries.

Recs

0
Member Avatar healthcarevalue (86.07) Submitted: 3/31/2015 6:43:30 PM : Outperform Start Price: $41.18 NASDAQ:ANIK Score: -41.85

ANIK - Anika Therapeutics Inc. - negligible to zero debt/equity ratio. Return on Invested Capital (ROIC) = 24.43 TTM. Price/earnings ratio of 16.4 TTM is reasonable. Niche biotech healthcare industry company specializing in therapeutic products for tissue repair and multiple different treatments in increasing demand by baby boomers.

Recs

0
Member Avatar puneetkataria (< 20) Submitted: 3/1/2015 1:47:37 AM : Outperform Start Price: $39.96 NASDAQ:ANIK Score: -35.92

Great fundamentals and a huge market for the products.

Leaderboard

Find the members with the highest scoring picks in ANIK.

Score Leader

zebradave

zebradave (65.24) Score: +1,020.27

God be with you.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
mechming < 20 12/7/2010 Outperform 5Y $5.53 +633.82% +133.79% +500.03 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. acts20 58.32 9/30/2011 Outperform NS $5.41 +650.09% +151.74% +498.35 2 Comments
siri22 < 20 9/1/2011 Outperform NS $6.00 +576.33% +136.94% +439.39 1 Comment
danculbertson 61.52 8/10/2010 Outperform 5Y $5.90 +587.80% +158.64% +429.16 0 Comment
vin100r < 20 8/12/2011 Outperform 3W $6.05 +570.74% +144.73% +426.02 0 Comment
germantownrockvi < 20 12/14/2010 Outperform 5Y $6.20 +554.52% +132.27% +422.25 0 Comment
cerroalegre 20.32 12/15/2010 Outperform 5Y $6.34 +540.06% +132.85% +407.22 0 Comment
mechincl < 20 10/25/2010 Outperform 5Y $6.33 +541.07% +143.21% +397.87 0 Comment
gsabc 79.97 6/25/2010 Outperform 5Y $6.16 +558.77% +168.94% +389.83 1 Comment
5starman 54.53 6/1/2011 Outperform 5Y $7.09 +472.36% +117.09% +355.26 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 86.17 10/28/2016 Outperform 3W $43.00 -5.63% +36.33% -41.96 0 Comment
TrackWayneRogers 58.21 11/29/2013 Outperform 3M $34.35 +18.14% +60.09% -41.95 0 Comment
tracksummerstree 87.67 9/19/2011 Outperform NS $5.72 +609.44% +143.27% +466.17 0 Comment
TrackNCPI < 20 11/7/2007 Outperform NS $14.86 -74.29% -47.61% -26.68 12/1/2008 @ $3.82 0 Comment

Advertisement